Infagel gel 10000 IU / g, 3g

• treatment of herpetic lesions of the skin and mucous membranes: simple and herpes zoster;

• recurrent herpes of the face, genitals, gingivitis, herpetic stomatitis; prevention of influenza and ARVI in adults who have had contact with patients with influenza and ARVI.

In the treatment of herpetic lesions, the gel is applied to the affected areas of the skin and mucous membranes with a thin layer 2 times / day with an interval of 12 hours and dried for 10-15 minutes to form a protective film. The duration of the course of treatment is from 3 to 5 days, until the complete disappearance of violations of the integrity of the skin and mucous membranes.

For the prevention of influenza and ARVI during periods of rising incidence, the drug is applied to the mucous membrane of the nasal passages 2 times / day with an interval of 12 hours during the first and third weeks of the course, in the second week they take a break.

Gel for local and external use in the form of a homogeneous mass of white or white with a grayish shade; delamination of the contents of the package is allowed, disappearing when shaken.

1 g human recombinant interferon alpha-2b 10,000 IU

Excipients: aluminum hydroxide - 57.8 mg, polyvinyl alcohol - from 17.5 mg, purified water - up to 1 g.

allergic diseases in the acute stage

pharmachologic effect

The recombinant interferon alpha-2b included in the gel has a wide spectrum of antiviral activity, bacteriostatic and anti-inflammatory effects, as well as antitumor and immunomodulatory activities.

Side effect

The drug has no side effects.

Drug interactions

For the treatment of inflammatory and viral diseases, the drug can be used as part of a combination therapy with antibacterial drugs, glucocorticoids, interferon inducers and antiviral drugs.